Cargando…
CD44 and RHAMM are essential for rapid growth of bladder cancer driven by loss of Glycogen Debranching Enzyme (AGL)
BACKGROUND: Loss of Amylo-alpha-1-6-glucosidase-4-alpha-glucanotransferase (AGL) drives rapid proliferation of bladder cancer cells by upregulating Hyaluronic acid(HA) Synthase (HAS2) mediated HA synthesis. However the role of HA receptors CD44 and Hyaluronan Mediated Motility Receptor (RHAMM) in re...
Autores principales: | Oldenburg, Darby, Ru, Yuanbin, Weinhaus, Benjamin, Cash, Steve, Theodorescu, Dan, Guin, Sunny |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011830/ https://www.ncbi.nlm.nih.gov/pubmed/27595989 http://dx.doi.org/10.1186/s12885-016-2756-5 |
Ejemplares similares
-
Glycogen debranching enzyme (AGL) is a novel regulator of non-small cell lung cancer growth
por: Richmond, Craig S., et al.
Publicado: (2018) -
Phylogenomic analysis of glycogen branching and debranching enzymatic duo
por: Zmasek, Christian M, et al.
Publicado: (2014) -
Uncovering the dual role of RHAMM as an HA receptor and a regulator of CD44 expression in RHAMM-expressing mesenchymal progenitor cells
por: Veiseh, Mandana, et al.
Publicado: (2015) -
Crystal structure of glycogen debranching enzyme and insights into its catalysis and disease-causing mutations
por: Zhai, Liting, et al.
Publicado: (2016) -
Clinical and Functional Characterization of Novel AGL Variants in Two Families with Glycogen Storage Disease Type III
por: Yu, Tingting, et al.
Publicado: (2023)